Search
Tony Keating says the study reveals many issues in the quality of cough recordings, and is not what the company expected.

ResApp crashes on study results

Shares in medical tech company ResApp Health plummeted 77 per cent today on disappointing results of a clinical study on its ResAppDx technology.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 31/03/20

1 year TSR5 year TSR
34thResApp Health127%85%
244thQuantify Technology Holdings0%-66%
446thrent.com.au-33%-30%
542nd333D-47%-52%
669 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

20/12/19
$0 Issued
20/12/19
$0 Issued
20/12/19
$0 Issued
Total value as at the date of the transaction
Powered by Morningstar ®

Revenue

104th↑ResApp Health$2.7m
116th↑rent.com.au$2.2m
117th↑333D$2.1m
119th↑Quantify Technology Holdings$1.8m
120th↑TikForce$1.8m
198 listed industrial companies ranked by revenue.
Powered by Morningstar ®